These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 25630291)
21. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism. Beyer-Westendorf J; Ageno W Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150 [TBL] [Abstract][Full Text] [Related]
22. Use of anticoagulants in elderly patients. Bauersachs RM Thromb Res; 2012 Feb; 129(2):107-15. PubMed ID: 22014849 [TBL] [Abstract][Full Text] [Related]
23. Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants. Ten Cate H; Henskens YM; Lancé MD Vasc Health Risk Manag; 2017; 13():457-467. PubMed ID: 29263674 [TBL] [Abstract][Full Text] [Related]
24. New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs). van Gorp RH; Schurgers LJ Nutrients; 2015 Nov; 7(11):9538-57. PubMed ID: 26593943 [TBL] [Abstract][Full Text] [Related]
25. Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation. Zoppellaro G; Granziera S; Padayattil Jose S; Denas G; Bracco A; Iliceto S; Pengo V Expert Opin Drug Saf; 2015 May; 14(5):683-95. PubMed ID: 25803739 [TBL] [Abstract][Full Text] [Related]
27. [Oral anticoagulation with vitamin K antagonists]. Alberio L Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470 [TBL] [Abstract][Full Text] [Related]
28. [Management of vitamin K antagonists in the elderly]. Belleville T; Pautas É; Gaussem P; Siguret V Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138 [TBL] [Abstract][Full Text] [Related]
29. Current challenges and future prospects in oral anticoagulant therapy. Czuprynska J; Patel JP; Arya R Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648 [TBL] [Abstract][Full Text] [Related]
36. Oral anticoagulant monitoring: Are we on the right track? Onundarson PT; Flygenring B Int J Lab Hematol; 2019 May; 41 Suppl 1():40-48. PubMed ID: 31069986 [TBL] [Abstract][Full Text] [Related]
37. [Biological monitoring and prevention of complications from antithrombotic agents]. Samama MM; Kher A Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1569-77. PubMed ID: 9092420 [TBL] [Abstract][Full Text] [Related]
38. Management of oral anticoagulant treatment in patients with venous thromboembolism. Pengo V Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590 [TBL] [Abstract][Full Text] [Related]
39. Novel anticoagulants and the future of anticoagulation. Garcia D Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505 [TBL] [Abstract][Full Text] [Related]
40. [Treatment of bleeding complications due to oral anticoagulant drugs]. Riess H Laryngorhinootologie; 2015 Oct; 94(10):697-709. PubMed ID: 26468622 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]